GMP non-compliance can spill over and impact patient access to life-saving medications.
Sharon Ayd
Advertisement
Sharon Ayd is chief scientific officer and SVP, Pharmaceuticals at Regulatory Compliance Associates.
Articles by Sharon Ayd
Creating a quality culture can prevent the costs and challenges associated with receiving a consent decree.
Advertisement
Latest Updated Articles
Managing the Cost of Non-CompliancePublished: November 2nd 2017 | Updated:
Impact of Non-Compliance on the American Healthcare ConsumerPublished: December 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
